Litigating Since 2003
Overview
Ever since his call to the Ontario Bar in 2003, Ariel has been involved in high-profile and complex litigation and has acted for international clients such as Bayer AG, Merck and Nissan. In fact, among other things, Ariel participated in a trial spanning 4 months that resulted in the largest reported Canadian damages award for patent infringement.
Prior to founding his own practice, Mr. Neuer clerked at the Superior Court of Justice in Ottawa, and subsequently practiced at specialized litigation boutiques, as well as in the litigation department of the renowned national firm, McCarthy Tétrault LLP.
Background and Other Interests
Ariel has published articles in legal journals and chapters in textbooks. He has also lectured at the University of Toronto Faculty of Law. Ariel enjoys speaking at legal conferences and participating in a variety of industry associations such as the Ontario Bar Association and the Intellectual Property Institute of Canada (IPIC).
Ariel has been actively involved in pro bono legal projects including those involving African refugee claimants and also on behalf of a major, Geneva-based, human rights UN non-governmental organization.
Education
Bar admission: Province of Ontario (Law Society of Upper Canada) - 2003
Juris Doctor, University of Toronto - 2001
B. Sc. (Chemistry), McGill Univeristy - 1998
Selected Publications
٠ “Motions to Discover an Inventor or Third Party”, Intellectual Property Litigation: Forms and Precedents, Ed. P. Lomic, 2016, LexisNexis, Toronto
٠ “Blind Justice”, A. Neuer and B. Reingold, Advocacy Matters, April 2016
٠ “Other Attacks on Validity”, W. Richardson and A. Neuer, Cameron's Patent and Trade-secrets Law, Ed. D. Cameron, 2011
٠A. Neuer, “Court of Appeal Serves Stiffer Shot in Trade-mark Expungement Applications”, Co-Counsel: Technology Law Quarterly, July 28, 2009, Volume 5, Issue 2
A. Neuer, “Distilling Trade-mark Law: Federal Court of Appeal (FCA) Issues Sobering Decision on Prohibited Marks”, Co-Counsel: Technology Law Quarterly, April 30, 2009, ٠ Volume 5, Issue 1
٠A. Neuer, “PMNOC Update: Efficiency and the Reversal of Evidence”, IP Thinking, February 2009, Vol. 1, Issue 1
٠A. Neuer, “Made in Canada: Federal Court of Appeal confirms the “obvious to try” test is different from the UK “worth a try” test in Apotex Inc. v. Pfizer Canada Inc. et al., 2009 FCA 8”.
Recently Reported Decisions
٠ Bayer AG et al v. Apotex Inc. / Cobalt Pharmaceutical Co., 2016 FC 1013
٠ Bayer Inc. et al v. Fresenius Canada Ltd. et al., 2016 FC 581
٠ Bayer Inc. v. Apotex Inc., 2014 FC 436
٠ Alcon Canada Inc. v. Cobalt Pharmaceuticals Company, 2014 FC 149
٠ Bayer Inc. v. Cobalt Pharmaceuticals Company, 2013 FC 1061 aff’d 2015 FCA 116